Data Missingness Reporting and Use of Methods to Address It in Critical Care Cohort Studies

Data Missingness Reporting and Use of Methods to Address It in Critical Care Cohort Studies

IMPORTANCE:. Failure to recognize and address data missingness in cohort studies may lead to biased results. Although Strengthening the Reporting of Observational Studies in Epidemiology reporting guidelines advocate data missingness reporting, the degree to which missingness is reported and address...

書誌詳細
主要な著者:	Ting Ting Wu, PharmD, Louisa H. Smith, PhD, Lisette M. Vernooij, PhD, Emi Patel, PharmD, John W. Devlin, PharmD, MCCM
フォーマット:	論文
言語:	English
出版事項:	Wolters Kluwer 2023-11-01
シリーズ:	Critical Care Explorations
オンライン･アクセス:	http://journals.lww.com/10.1097/CCE.0000000000001005

類似資料

Relationship Between Pain and Delirium in Critically Ill Adults
著者:: Ting Ting Wu, PharmD, BCCCP, 等
出版事項: (2023-12-01)

Impact of the 2018 Society of Critical Care Medicine Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Guidelines on Nonopioid Analgesic Use and Related Outcomes in Critically Ill Adults After Major Surgery
著者:: Spencer Sutton, PharmD, 等
出版事項: (2021-10-01)

Characterization of Nocturnal Neuroactive Medication Use and Related Sleep Documentation in Critically Ill Adults
著者:: Arzo Hamidi, PharmD, 等
出版事項: (2021-03-01)

Baseline Anxiety and Depression and Risk for ICU Delirium: A Prospective Cohort Study
著者:: Ting Ting Wu, PharmD, 等
出版事項: (2022-07-01)

Exploring Ketamine Analgosedation Use and Its Effect on Incident Delirium in Critically Ill Adults
著者:: Ting Ting Wu, PharmD, 等
出版事項: (2021-10-01)

Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
著者:: Rachel M. Belcher, PharmD, BCCCP, 等
出版事項: (2023-01-01)

Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with COVID-19: A Multicenter Cohort Study
著者:: Raed Kensara BSc.Pharm, SCC-CCP, BCPS, 等
出版事項: (2023-02-01)

Nanocarriers Call the Last Shot in the Treatment of Brain Cancers
著者:: Amin Mehrabian PharmD, PhD, 等
出版事項: (2022-03-01)

Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study
著者:: Khalid Al Sulaiman MBA, BCCCP, BCNSP, FCCM, 等
出版事項: (2023-06-01)

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
著者:: Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, 等
出版事項: (2023-12-01)

Drug-induced hypersensitivity reactions in a Lebanese outpatient population: A decade-long retrospective analysis (2012-2021)
著者:: Joelle Dagher, PharmD, PhD, 等
出版事項: (2024-02-01)

Teaching the Philosophy of Practice as a Key Component of Pharmaceutical Care Practice
著者:: Keri Hager, 等
出版事項: (2018-03-01)

The Role of Date Palm ( L) Pollen in Fertility
著者:: Mohammad Tahvilzadeh PharmD, PhD Candidate, 等
出版事項: (2016-10-01)

Anticonvulsant Effects of Aerial Parts of Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors
著者:: Amir Rashidian PharmD, PhD, 等
出版事項: (2017-10-01)

Major Publications in the Critical Care Pharmacotherapy Literature: 2023
著者:: Brian Murray, PharmD, 等
出版事項: (2024-10-01)

An Evidence-Based Review on Wound Healing Herbal Remedies From Reports of Traditional Persian Medicine
著者:: Ayda Hosseinkhani PharmD, PhD, 等
出版事項: (2017-04-01)

Adverse childhood experiences among California student pharmacists
著者:: Shawn R. Smith, PharmD, APh, 等
出版事項: (2024-02-01)

Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature
著者:: Girish B S, Pharm.D, 等
出版事項: (2024-12-01)

Major Publications in the Critical Care Pharmacotherapy Literature: 2021
著者:: Patrick M. Wieruszewski, PharmD, 等
出版事項: (2022-12-01)

Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review
著者:: Michael Behal, PharmD, 等
出版事項: (2021-07-01)

Randomized Clinical Trial of Peganum Oil for Knee Osteoarthritis
著者:: Zohreh Abolhassanzadeh PharmD, PhD, 等
出版事項: (2015-04-01)

Cefepime Daily Exposure and the Associated Impact on the Change in Sequential Organ Failure Assessment Scores and Vasopressors Requirement in Critically Ill Patients Using Repeated-Measures Mixed-Effect Modeling
著者:: Mohammad H. Alshaer, PharmD, PhD, 等
出版事項: (2023-11-01)

Healthcare Providers’ Perspectives Toward the Integration of over the Counter Supplements During COVID-19 Pandemic: A Cross-Sectional Study from Jordan
著者:: Samah F. Al-Shatnawi PharmD, PhD, 等
出版事項: (2022-04-01)

Reformulation of Traditional Chamomile Oil: Quality Controls and Fingerprint Presentation Based on Cluster Analysis of Attenuated Total Reflectance–Infrared Spectral Data
著者:: Arman Zargaran PharmD, PhD, 等
出版事項: (2017-10-01)

Consumer perception, knowledge, and uses of cannabidiol
著者:: Nguyen Cambrey PharmD, 等
出版事項: (2023-10-01)

Sweet Marjoram
著者:: Fatemeh Bina PharmD, PhD Candidate, 等
出版事項: (2017-01-01)

Assessing intradisciplinary pharmacy communication related to transitions of care
著者:: Letitia N. Warunek, PharmD, BCPS, 等
出版事項: (2024-06-01)

International Market Access Strategies for Artificial Intelligence–Based Medical Devices: Can We Standardize the Process to Faster Patient Access?
著者:: Line Farah, Pharm D, 等
出版事項: (2023-09-01)

Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis
著者:: Awatif Hafiz PharmD, BCCP, 等
出版事項: (2023-08-01)

Clinical Characteristics and Outcomes of Deep Vein Thrombosis in Relation to Location: A Retrospective Analysis Study
著者:: Majed S. Al Yami PharmD, 等
出版事項: (2025-01-01)

Anticoagulation in COVID-19: DDI Perspective
著者:: Sajad Khiali PharmD, 等
出版事項: (2020-09-01)

Prevalence and Risk Factors for Iatrogenic Opioid Withdrawal in Medical Critical Care Patients
著者:: Marlena A. Fox, PharmD, BCPS, BCCCP, 等
出版事項: (2023-05-01)

The Drug Court Pharmacist: Expanding Pharmacy Practice and Addressing Substance Abuse
著者:: Laura C Palombi, PharmD, 等
出版事項: (2016-10-01)

Comparison of Fixed Versus Weight-Based Prothrombin Complex Concentrate Dosing Strategies for Factor Xa Inhibitor Reversal
著者:: Snyder Brett PharmD, 等
出版事項: (2024-05-01)

Primary Care Providers’ experiences with Pharmaceutical Care-based Medication Therapy Management Services
著者:: Heather L. Maracle, Pharm.D., 等
出版事項: (2012-01-01)

Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations
著者:: Nicole K. Wilson, PharmD, MS, BCTXP, 等
出版事項: (2024-08-01)

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
著者:: Abdulaali R. Almutairi PhD, 等
出版事項: (2025-02-01)

Characterizing Critical Care Pharmacy Services Across the United States
著者:: Robert MacLaren, PharmD, MPH, FCCM, FCCP, 等
出版事項: (2021-01-01)

Contraceptive Use and Missed Opportunities for Family Planning Discussions in Women Living with Human Immunodeficiency Virus at an HIV Clinic
著者:: Ashley Winters PharmD, 等
出版事項: (2022-12-01)

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns
著者:: Danielle Dauchot, PharmD, 等
出版事項: (2024-02-01)